Connect Sign In
LabMind podcasts
The 36th Annual Park City Anatomic Pathology Update will offer an opportunity for pathologists to connect and share best practices in hematopathology and genitourinary (GU) pathology, including how to apply the latest updates from the World Health Organization (WHO) on the classification of tumors. |
November 16, 2022 |
Park City Anatomic Pathology Update Promises Guidance on Practical Application of Latest WHO Updates The University of Utah Department of Pathology and ARUP Laboratories will host the 36th Annual Park City Anatomic Pathology Update from February 5–9, 2023. |
ARUP President and Chief Scientific Officer Tracy George, MD (center), joins Kate Benedict, worldwide vice president/general manager of vascular access devices at BD, and Jared Bauer, CEO of Seek Labs, on a Workplace Innovation panel at the 2022 BioHive Summit to discuss workforce retention. |
November 11, 2022 |
President Tracy George, MD, Discusses ARUP’s Employee Focus at the 2022 BioHive Summit ARUP President and CSO Tracy George, MD, joined industry leaders and stakeholders at the 13th annual BioHive Summit Thursday to discuss ARUP’s employee focus, staff retention, and company culture. |
New automation installed in the Automated Core Lab increases ARUP’s testing capacity, provides better turnaround times, reduces risk of human error, and improves staff satisfaction. |
November 10, 2022 |
Q&A With Key Players in Development of Total Automation in the ARUP Automated Core Lab The near total automation installed in ARUP’s Automated Core Lab increases capacity for testing, provides better turnaround times, reduces risk of human error, and improves staff satisfaction. |
|
November 9, 2022 |
ARUP Announces Successful Completion of CAP ISO 15189 Assessment ARUP’s International Organization for Standardization (ISO) 15189 accreditation assessment has successfully concluded, and results confirm the consistently high quality of ARUP’s operations. |
Pinar Bayrak-Toydemir, MD, PhD, FACMG (left), and Rong Mao, MD, FACMG (right), medical directors of Molecular Genetics and Genomics, lend their expertise to the diagnosis of rare childhood disorders through the Utah NeoSeq Project. |
November 8, 2022 |
Miller Family Gift Expands U of U Health/ARUP Efforts to Diagnose Rare Disorders A $3.6 million gift from the Miller family will enable University of Utah Health and ARUP to expand and refine testing for rare genetic disorders through the Utah NeoSeq Project. |
Mounting evidence suggests that kratom may lead to neonatal abstinence syndrome (NAS) in infants exposed to the substance in utero. |
November 8, 2022 |
New ARUP Test Detects Fetal Exposure to Kratom to Aid in Management of Neonatal Abstinence Syndrome ARUP’S new test is the first of its kind to use two distinct biomarkers to identify in utero exposure to kratom, an herbal supplement that may cause neonatal abstinence syndrome. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine We accelerate groundbreaking diagnostic and prognostic technologies to drive life-changing innovation. Our large, single-site operation and renowned quality framework, combined with our extensive expertise, provide an ideal incubator to advance custom projects for innovative partners. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat